Department of Surgery, Washington University School of Medicine, Wales, UK.
Health Expect. 2011 Mar;14(1):84-91. doi: 10.1111/j.1369-7625.2010.00626.x. Epub 2010 Sep 23.
Given the large number of interventions of uncertain effectiveness, research on communicating uncertainty is needed to examine its impact on patients' health decisions.
To examine physicians' communication of uncertainty and its impact on patients' decisions and decision satisfaction.
DESIGN, SETTING, AND PARTICIPANTS: Participants included female patients seen in a breast health centre whose physicians were discussing a decision with them, with no clear 'best' choice based on outcome evidence.
Decision communication was measured using the OPTION scale, a measure of the degree to which physicians involve patients in a decision-making process. One-to-two weeks after the discussion, patients reported their satisfaction with the decision-making process and their decision. Decisions were verified in medical charts with patient consent.
Seventy-five women agreed to participate (94% response rate). The mean translated score of the OPTION scale was 68.0 (SD 18.3), but only 33.2 (SD 19.1) for the uncertainty items. Among cancer patients, communicating uncertainty was negatively related to decision satisfaction (P < 0.002), and there was an interaction between patient involvement in decisions and communicating uncertainty in relation to patients' decision satisfaction (P < 0.03).
Communicating scientific uncertainty might lead to less decision satisfaction among women facing cancer treatment decisions; this could be a natural outcome of the decision making process. Involving patients in decisions might help them tolerate uncertainty.
Future studies should consider assessing other outcomes (e.g. knowledge, physician support) of the decision making process. There may be trade-offs between acknowledging uncertainty and immediate decision satisfaction.
鉴于大量效果不确定的干预措施,需要研究沟通不确定性,以检验其对患者健康决策的影响。
考察医生沟通不确定性及其对患者决策和决策满意度的影响。
设计、地点和参与者:参与者包括在乳腺健康中心就诊的女性患者,其医生正在与她们讨论一个决策,根据结果证据,没有明确的“最佳”选择。
使用 OPTION 量表衡量决策沟通,该量表衡量医生在决策过程中让患者参与的程度。在讨论后的 1 到 2 周内,患者报告了他们对决策过程和决策的满意度。在获得患者同意的情况下,在病历中验证决策。
75 名女性同意参与(94%的回复率)。OPTION 量表的平均翻译分数为 68.0(SD 18.3),但不确定性项目的平均分数仅为 33.2(SD 19.1)。在癌症患者中,沟通不确定性与决策满意度呈负相关(P < 0.002),并且患者参与决策和沟通不确定性与患者决策满意度之间存在交互作用(P < 0.03)。
在面临癌症治疗决策的女性中,沟通科学不确定性可能会导致较低的决策满意度;这可能是决策过程的自然结果。让患者参与决策可能有助于他们容忍不确定性。
未来的研究应考虑评估决策过程的其他结果(例如知识、医生支持)。在承认不确定性和即时决策满意度之间可能存在权衡。